1. Andersson, M., A. McMichael, and P. A. Peterson. 1987. Reduced allorecognition
of adenovirus-2 infected cells. J. Immunol. 138:3960–3966.
2. Bacon, L., R. A. Eagle, M. Meyer, N. Easom, N. T. Young, and J. Trowsdale.
2004. Two human ULBP/RAET1 molecules with transmembrane regions
are ligands for NKG2D. J. Immunol. 173:1078–1084.
3. Bauer, S., V. Groh, J. Wu, A. Steinle, J. H. Phillips, L. L. Lanier, and T.
Spies. 1999. Activation of NK cells and T cells by NKG2D, a receptor for
stress-inducible MICA. Science 285:727–729.
4. Beier, D. C., J. H. Cox, D. R. Vining, P. Cresswell, and V. H. Engelhard. 1994.
Association of human class I MHC alleles with the adenovirus E3/19K
protein. J. Immunol. 152:3862–3872.
5. Benedict, C. A., P. S. Norris, T. I. Prigozy, J. L. Bodmer, J. A. Mahr, C. T.
Garnett, F. Martinon, J. Tschopp, L. R. Gooding, and C. F. Ware. 2001.
Three adenovirus E3 proteins cooperate to evade apoptosis by tumor necrosis
factor-related apoptosis-inducing ligand receptor-1 and -2. J. Biol.
Chem. 276:3270–3278.
6. Bett, A. J., V. Krougliak, and F. L. Graham. 1995. DNA sequence of the
deletion/insertion in early region 3 of Ad5 dl309. Virus Res. 39:75–82.
7. Burgert, H.-G., and J. H. Blusch. 2000. Immunomodulatory functions encoded
by the E3 transcription unit of adenoviruses. Virus Genes. 21:13–25.
8. Burgert, H.-G., and S. Kvist. 1985. An adenovirus type 2 glycoprotein blocks
cell surface expression of human histocompatibility class I antigens. Cell
41:987–997.
9. Burgert, H.-G., and S. Kvist. 1987. The E3/19K protein of adenovirus type 2
binds to the domains of histocompatibility antigens required for CTL recognition.
EMBO J. 6:2019–2026.
10. Burgert, H.-G., J. L. Maryanski, and S. Kvist. 1987. “E3/19K” protein of
adenovirus type 2 inhibits lysis of cytolytic T lymphocytes by blocking cellsurface
expression of histocompatibility class I antigens. Proc. Natl. Acad.
Sci. USA 84:1356–1360.
11. Burgert, H.-G., Z. Ruzsics, S. Obermeier, A. Hilgendorf, M. Windheim, and
A. Elsing. 2002. Subversion of host defense mechanisms by adenoviruses.
Curr. Top. Microbiol. Immunol. 269:273–318.
12. Carlin, C. R., A. E. Tollefson, H. A. Brady, B. L. Hoffman, and W. S. Wold.
1989. Epidermal growth factor receptor is down-regulated by a 10,400 MW
protein encoded by the E3 region of adenovirus. Cell 57:135–144.
13. Chalupny, N. J., A. Rein-Weston, S. Dosch, and D. Cosman. 2006. Downregulation
of the NKG2D ligand MICA by the human cytomegalovirus
glycoprotein UL142. Biochem. Biophys. Res. Commun. 346:175–181.
14. Chan, C. W., E. Crafton, H. N. Fan, J. Flook, K. Yoshimura, M. Skarica, D.
Brockstedt, T. W. Dubensky, M. F. Stins, L. L. Lanier, D. M. Pardoll, and F.
Housseau. 2006. Interferon-producing killer dendritic cells provide a link
between innate and adaptive immunity. Nat. Med. 12:207–213.
15. Cook, J. L., C. K. Krantz, and B. A. Routes. 1996. Role of p300-family
proteins in E1A oncogene induction of cytolytic susceptibility and tumor cell
rejection. Proc. Natl. Acad. Sci. USA 93:13985–13990.
16. Cosman, D., J. Mullberg, C. L. Sutherland, W. Chin, R. Armitage, W.
Fanslow, M. Kubin, and N. J. Chalupny. 2001. ULBPs, novel MHC class
I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK
cytotoxicity through the NKG2D receptor. Immunity 14:123–133.
17. Cox, J. H., J. R. Bennink, and J. W. Yewdell. 1991. Retention of adenovirus
E19 glycoprotein in the endoplasmic reticulum is essential to its ability to
block antigen presentation. J. Exp. Med. 174:1629–1637.
18. Elsing, A., and H.-G. Burgert. 1998. The adenovirus E3/10.4K-14.5K proteins
down-modulate the apoptosis receptor Fas/Apo-1 by inducing its internalization.
Proc. Natl. Acad. Sci. USA 95:10072–10077.
19. Feuerbach, D., S. Etteldorf, C. Ebenau-Jehle, J. P. Abastado, D. Madden,
and H.-G. Burgert. 1994. Identification of amino acids within the MHC
molecule important for the interaction with the adenovirus protein E3/19K.
J. Immunol. 153:1626–1636.
20. Flomenberg, P., E. Gutierrez, and K. T. Hogan. 1994. Identification of class
I MHC regions which bind to the adenovirus E3-19k protein. Mol. Immunol.
31:1277–1284.
21. Flomenberg, P., V. Piaskowski, R. L. Truitt, and J. T. Casper. 1996. Human
adenovirus-specific CD8� T-cell responses are not inhibited by E3-19K in
the presence of gamma interferon. J. Virol. 70:6314–6322.
22. Gasser, S., S. Orsulic, E. J. Brown, and D. H. Raulet. 2005. The DNA
damage pathway regulates innate immune system ligands of the NKG2D
receptor. Nature 436:1186–1190.
23. Groh, V., S. Bahram, S. Bauer, A. Herman, M. Beauchamp, and T. Spies.
1996. Cell stress-regulated human major histocompatibility complex class I
gene expressed in gastrointestinal epithelium. Proc. Natl. Acad. Sci. USA
93:12445–12450.
24. Hilgendorf, A., J. Lindberg, Z. Ruzsics, S. Ho¨ning, A. Elsing, M. Lo¨fqvist, H.
Engelmann, and H.-G. Burgert. 2003. Two distinct transport motifs in the
adenovirus E3/10.4-14.5 proteins act in concert to down-modulate apoptosis
receptors and the epidermal growth factor receptor. J. Biol. Chem. 278:
51872–51884.
25. Holmes, M. A., P. Li, E. W. Petersdorf, and R. K. Strong. 2002. Structural
studies of allelic diversity of the MHC class I homolog MIC-B, a stressinducible
ligand for the activating immunoreceptor NKG2D. J. Immunol.
169:1395–1400.
26. Horton, T. M., T. S. Ranheim, L. Aquino, D. I. Kusher, S. K. Saha, C. F.
Ware, W. S. Wold, and L. R. Gooding. 1991. Adenovirus E3 14.7K protein
functions in the absence of other adenovirus proteins to protect transfected
cells from tumor necrosis factor cytolysis. J. Virol. 65:2629–2639.
27. Jackson, M. R., T. Nilsson, and P. A. Peterson. 1993. Retrieval of transmembrane
proteins to the endoplasmic reticulum. J. Cell Biol. 121:317–333.
28. Jacobs, S. C., A. J. Davison, S. Carr, A. M. Bennett, R. Phillpotts, and G. W.
Wilkinson. 2004. Characterization and manipulation of the human adenovirus
4 genome. J. Gen. Virol. 85:3361–3366.
29. Katsuyama, Y., M. Ota, H. Ando, S. Saito, N. Mizuki, J. Kera, S. Bahram,
Y. Nose, and H. Inoko. 1999. Sequencing based typing for genetic polymorphisms
in exons, 2, 3 and 4 of the MICA gene. Tissue Antigens 54:178–184.
30. Ko¨rner, H., U. Fritzsche, and H.-G. Burgert. 1992. Tumor necrosis factor
alpha stimulates expression of adenovirus early region 3 proteins: implications
for viral persistence. Proc. Natl. Acad. Sci. USA 89:11857–11861.
31. Leon, R. P., T. Hedlund, S. J. Meech, S. Li, J. Schaack, S. P. Hunger, R. C.
Duke, and J. DeGregori. 1998. Adenoviral-mediated gene transfer in lymphocytes.
Proc. Natl. Acad. Sci. USA 95:13159–13164.
32. Li, P., S. T. Willie, S. Bauer, D. L. Morris, T. Spies, and R. K. Strong. 1999.
Crystal structure of the MHC class I homolog MIC-A, a gammadelta T cell
ligand. Immunity 10:577–584.
33. Lichtenstein, D. L., K. Toth, K. Doronin, A. E. Tollefson, and W. S. Wold.
2004. Functions and mechanisms of action of the adenovirus E3 proteins. Int.
Rev. Immunol. 23:75–111.
34. Liu, H., W. F. Stafford, and M. Bouvier. 2005. The endoplasmic reticulum
lumenal domain of the adenovirus type 2 E3-19K protein binds to peptide-filled
and peptide-deficient HLA-A*1101 molecules. J. Virol. 79:13317–13325.
35. Marin, M. L., C. R. Savioli, J. H. Yamamoto, J. Kalil, and A. C. Goldberg.
2004. MICA polymorphism in a sample of the Sao Paulo population, Brazil.
Eur. J. Immunogenet. 31:63–71.
36. McCann, F. E., P. Eissmann, B. Onfelt, R. Leung, and D. M. Davis. 2007.
The activating NKG2D ligand MHC class I-related chain A transfers from
target cells to NK cells in a manner that allows functional consequences.
J. Immunol. 178:3418–3426.
37. McSharry, B. P., C. J. Jones, J. W. Skinner, D. Kipling, and G. W. Wilkinson.
2001. Human telomerase reverse transcriptase-immortalized MRC-5
and HCA2 human fibroblasts are fully permissive for human cytomegalovirus.
J. Gen. Virol. 82:855–863.
38. Munoz-Saa, I., A. Cambra, L. Pallares, G. Espinosa, A. Juan, F. Pujalte, N.
Matamoros, J. Mila, and M. R. Julia. 2006. Allelic diversity and affinity
variants of MICA are imbalanced in Spanish patients with Behcet’s disease.
Scand. J. Immunol. 64:77–82.
39. Routes, J. M., S. Ryan, K. Morris, R. Takaki, A. Cerwenka, and L. L. Lanier.
2005. Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent
NK cell lysis and tumor rejection. J. Exp. Med. 202:1477–1482.
40. Sester, M., and H.-G. Burgert. 1994. Conserved cysteine residues within the
E3/19K protein of adenovirus type 2 are essential for binding to major
histocompatibility complex antigens. J. Virol. 68:5423–5432.
41. Sester, M., D. Feuerbach, R. Frank, T. Preckel, A. Gutermann, and H.-G.
Burgert. 2000. The amyloid precursor-like protein 2 associates with the
major histocompatibility complex class I molecule K (d). J. Biol. Chem.
275:3645–3654.
42. Stam, N. J., T. M. Vroom, P. J. Peters, E. B. Pastoors, and H. L. Ploegh.
1990. HLA-A- and HLA-B-specific monoclonal antibodies reactive with free
heavy chains in western blots, in formalin-fixed, paraffin-embedded tissue
sections and in cryo-immuno-electron microscopy. Int. Immunol. 2:113–125.
43. Stern-Ginossar, N., N. Elefant, A. Zimmermann, D. G. Wolf, N. Saleh, M.
Biton, E. Horwitz, Z. Prokocimer, M. Prichard, G. Hahn, D. Goldman-Wohl,
C. Greenfield, S. Yagel, H. Hengel, Y. Altuvia, H. Margalit, and O. Mandelboim.
2007. Host immune system gene targeting by a viral miRNA. Science
317:376–381.
44. Tollefson, A. E., T. W. Hermiston, D. L. Lichtenstein, C. F. Colle, R. A.
Tripp, T. Dimitrov, K. Toth, C. E. Wells, P. C. Doherty, and W. S. Wold.
1998. Forced degradation of Fas inhibits apoptosis in adenovirus-infected
cells. Nature 392:726–730.
45. Tollefson, A. E., A. R. Stewart, S. P. Yei, S. K. Saha, and W. S. Wold. 1991.
The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus
form a complex and function together to down-regulate the epidermal
growth factor receptor. J. Virol. 65:3095–3105.
46. Tomasec, P., V. M. Braud, C. Rickards, M. B. Powell, B. P. McSharry, S.
Gadola, V. Cerundolo, L. K. Borysiewicz, A. J. McMichael, and G. W.
Wilkinson. 2000. Surface expression of HLA-E, an inhibitor of natural killer
cells, enhanced by human cytomegalovirus gpUL40. Science 287:1031.
47. Tomasec, P., E. C. Wang, A. J. Davison, B. Vojtesek, M. Armstrong, C.
Griffin, B. P. McSharry, R. J. Morris, S. Llewellyn-Lacey, C. Rickards, A.
Nomoto, C. Sinzger, and G. W. Wilkinson. 2005. Downregulation of natural
killer cell-activating ligand CD155 by human cytomegalovirus UL141. Nat.
Immunol. 6:181–188.
48. Tomasec, P., E. C. Wang, V. Groh, T. Spies, B. P. McSharry, R. J. Aicheler,
R. J. Stanton, and G. W. Wilkinson. 2007. Adenovirus vector delivery stimulates
natural killer cell recognition. J. Gen. Virol. 88:1103–1108.
49. Warming, S., N. Costantino, D. L. Court, N. A. Jenkins, and N. G. Copeland.
2005. Simple and highly efficient BAC recombineering using galK selection.
Nucleic Acids Res. 33:e36.
50. Wilkinson, G. W., and A. Akrigg. 1992. Constitutive and enhanced expression
from the CMV major IE promoter in a defective adenovirus vector.
Nucleic Acids Res. 20:2233–2239.
51. Windheim, M., A. Hilgendorf, and H.-G. Burgert. 2004. Immune evasion by
adenovirus E3 proteins: exploitation of intracellular trafficking pathways.
Curr. Top. Microbiol. Immunol. 273:29–85.
52. Wold, W. S., and M. S. Horwitz. 2007. Adenoviruses, p. 2395–2436. In B. N.
Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 5th ed., vol. 2.
Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia, PA.
53. Zou, Y., W. Bresnahan, R. T. Taylor, and P. Stastny. 2005. Effect of human
cytomegalovirus on expression of MHC class I-related chains A. J. Immunol.
174:3098–3104.
54. Zou, Y., M. Han, Z. Wang, and P. Stastny. 2006. MICA allele-level typing by
sequence-based typing with computerized assignment of polymorphic sites
and short tandem repeats within the transmembrane region. Hum. Immunol.
67:145–151.
55. Zwirner, N. W., C. Y. Marcos, F. Mirbaha, Y. Zou, and P. Stastny. 2000.
Identification of MICA as a new polymorphic alloantigen recognized by
antibodies in sera of organ transplant recipients. Hum. Immunol. 61:917–
924.